Gyre Therapeutics (L9S.F) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.09
-0.04
-0
0.04

Details

Expected EPS
-0.06252884910999999
Actual EPS
-0.08526700000000001
Surprise EPS
-0.02
Surprise Percent
-36.36%

Description

⁨Gyre Therapeutics⁩ (⁦L9S.F⁩) has reported earnings of ⁦-0.08526700000000001⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts